A mouse model of hereditary pancreatitis generated by transgenic expression of R122H trypsinogen. Read more about A mouse model of hereditary pancreatitis generated by transgenic expression of R122H trypsinogen.
Embarrassment is a major barrier to colon cancer prevention, especially among women: a call to action. Read more about Embarrassment is a major barrier to colon cancer prevention, especially among women: a call to action.
Sustained phosphorylation of Bid is a marker for resistance to Fas-induced apoptosis during chronic liver diseases. Read more about Sustained phosphorylation of Bid is a marker for resistance to Fas-induced apoptosis during chronic liver diseases.
Colonoscopy is superior to flexible sigmoidoscopy for colorectal cancer screening: now beyond a reasonable doubt? Read more about Colonoscopy is superior to flexible sigmoidoscopy for colorectal cancer screening: now beyond a reasonable doubt?
It is time to get serious about diagnosing Lynch syndrome (hereditary nonpolyposis colorectal cancer with defective DNA mismatch repair) in the general population. Read more about It is time to get serious about diagnosing Lynch syndrome (hereditary nonpolyposis colorectal cancer with defective DNA mismatch repair) in the general population.
Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients. Read more about Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients.
Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11. Read more about Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11.
Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity. Read more about Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity.
Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B. Read more about Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.
